Skip to main content
CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-05-29

Utility of tumor antigens as therapeutic and diagnostic tools

Ziel

The serological profiling of anti-tumour associated antigen responses through large- scale efforts has identified over 2000 antigens. Our preliminary results show a correlation between antibody responses against a number of these with parameters indicative of indolent disease and with longer overall survival in lung cancer patients. The first aim of this project is to extend and establish these observations. Since these are antigens primarily expressed by tissues of neuroectodermal origin, we want to prove the absence of an association of antibodies against them and autoimmune paraneoplastic neuronal degeneration.

Aufforderung zur Vorschlagseinreichung

FP6-2004-MOBILITY-12
Andere Projekte für diesen Aufruf anzeigen

Koordinator

BILKENT UNIVERSITESI
EU-Beitrag
Keine Daten
Adresse
Eskisehir Yolu 8.km. Bilkent Ankara, Turkey
BILKENT, ANKARA
Türkei

Auf der Karte ansehen

Links
Gesamtkosten
Keine Daten